TAIEquity · Weekly research terminal

6589

EirGenix Inc.

TW Healthcare Biotechnology

Latest week
7 Aug 2026
Weekly close
48.20 TWD
Fair value
75.71 TWD
Next-week expectancy
Negative 38.31%
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TAI · Equity · Taiwan

6589

EirGenix Inc.

Healthcare Biotechnology

EirGenix Inc. operates as a contract development and manufacturing company in Taiwan and internationally. The company offers cell line development, process development, analytical and quality control, cGMP manufacturing mammalian and microbial system, and antibody-drug conjugate services. It is also involved in the development of EG12014/EGI014, a Trastuzumab biosimilar, indicated for the treatment of cancer and currently under biologics license application status; EG1206A, a Pertuzumab biosimilar, indicated for the treatment of cancer and …

Last updated
7 Aug 2026
Exchange
Taiwan Stock Exchange · TAI
Sector
Healthcare
Industry
Biotechnology
Currency
TWD
Market capitalisation
15,598,387,200
Fair value reference
75.71
Next-week expectancy
Negative · 38.31%

Over the latest 12 completed weeks ending 2026-08-07, 6589 rose 10.30%, moving from 43.70 to 48.20. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -41.82 and has improved across the 12-week window. Market Dynamics is 0.41 on the latest week. Next-week expectancy is negative at 38.31% based on similar historical setup states.

Week Ending
7 Aug 2026
Latest Close
48.20
12-Week Change
10.30%
Trend Signal
Inactive
Next-Week Expectancy
Negative 38.31%
Signal Weeks
0 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
7 Aug 2026
Latest Close
48.20
12-Week Change
10.30%
Trend Signal
Inactive
Next-Week Expectancy
Negative 38.31%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-41.82
Market Dynamics
0.41

Over the latest 12 completed weeks ending 2026-08-07, 6589 rose 10.30%, moving from 43.70 to 48.20. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -41.82 and has improved across the 12-week window. Market Dynamics is 0.41 on the latest week. Next-week expectancy is negative at 38.31% based on similar historical setup states.

Industry Peers

Taiwan equities in Biotechnology

Stock Exchange Week Open High Low Close Change
6949 Pell Bio-Med Technology Co., Ltd. TAI 7 Aug 2026 800.00 999.00 799.00 943.00 17.88%
1762 Chunghwa Chemical Synthesis & Biotech Co., Ltd. TAI 7 Aug 2026 32.20 35.75 31.60 35.75 11.02%
7827 HanchorBio Inc. TAI 7 Aug 2026 144.50 157.50 144.50 156.00 7.96%
4142 Adimmune Corporation TAI 7 Aug 2026 16.55 17.80 16.45 17.70 6.95%
4178 StemCyte International, Ltd. TAI 7 Aug 2026 17.40 19.00 17.40 18.40 5.75%
6919 CALIWAY BIOPHARMACEUTICALS CO L TAI 7 Aug 2026 102.00 111.00 102.00 105.00 2.94%
6541 Tanvex BioPharma, Inc. TAI 7 Aug 2026 37.10 38.45 36.60 38.05 2.56%
6657 Energenesis Biomedical CO.,LTD. TAI 7 Aug 2026 30.50 31.55 29.40 31.20 2.30%
1733 Apex Biotechnology Corp. TAI 7 Aug 2026 31.30 33.10 30.80 32.00 2.24%
4133 Abnova (Taiwan) Corporation TAI 7 Aug 2026 20.75 21.85 20.75 21.20 2.17%
3164 GenMont Biotech Incorporation TAI 7 Aug 2026 16.25 16.60 16.00 16.40 0.92%
6885 BRIM Biotechnology, Inc. TAI 7 Aug 2026 20.95 21.20 20.50 21.10 0.72%
6550 Polaris Group TAI 7 Aug 2026 11.05 11.35 10.90 11.10 0.45%
1734 Sinphar Pharmaceutical Co.,Ltd. TAI 7 Aug 2026 31.70 31.80 31.30 31.80 0.32%
4169 TCM Biotech International Corp. TAI 7 Aug 2026 158.00 167.50 153.00 157.00 -0.63%
6838 Formosa Pharmaceuticals, Inc. TAI 7 Aug 2026 23.40 23.75 22.80 23.20 -0.85%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context